2Kooijmans-Coutinho MF, Hermans J, Schrama E, et al. Interstitial rejection, vascular rejection, and diffuse thrombosis of renal allografts.Transplantation, 1996,61 : 1338.
3Feucht HE, Felber E, Gokel MJ, et al. Vascular deposition of complement-split products in kidney allografts with cell-mediated rejection. Clin Exp Immunol, 1991,86:464.
4Feucht HE, Schneeberger H, Hillebrand G, et al. Capillary deposition of C4d complement fragment and early renal graft loss. Kidney Int, 1993,43:1333.
5Collins AB, Schneeberger EE, Pascual MA, et al. Complement activation in acute humoral:renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries. J Am Soc Nephrol, 1999, 10:2208.
6Colvin RB, Cohen All, Saiontz C, et al. Evaluation of pathologic criteria for acute allograft rejection: Reproducibility, sensitivity, and clinical correlation. J Am Sot Nephrol, 1997,8:1930.
7Platt JL. C4d and the fate of organ allografts. J Am Soc Nephrol, 2002,13 : 2417.
8Watschimger B, Pascual M. Capillary C4d deposition as a marker of humoral immunity in renal allograft rejection. J Am Soc Nephrol, 2002,13 :2420.
9Regele H, Bohmig GA, Habicht A, et al. Capillary deposition of complement split product C4d in renal allograft is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity of chronic allograft rejection. J Am Soc Nephrol,2002.13:2371.
10Mauiyyedi S, Crespo M, Collins AB, et al. Acute humoral rejection in kidney transplantation: Ⅱ. morphology, immunopathology, and pathologic classification. J Am Soc Nephrol, 2002,13:779.
2Terasaki PI. Deduction of the fraction of immunologic and non-im-munologic failure in cadaver donor transplants. Clinical Trans-plants,2003,449452.
3Mauiyyedi S,Crespo M,Collins AB,et al. Acute humoral rejectionin kidney transplantati- on: II Morphology, immunopathology andpathologic classification. J Am Soc Nephrol, 2002,13 (3 ) :779-787.
4Regele H. Non-HLA antibodies in kidney allograft rejection: con-vincing concept in need of further evidence. Kidney Int,2011,79(6) :583-586.
5Wang R,wang H,Chen J,et al. C4d deposition in allograft renalbiopsies is an independent risk fact for graft faiure. Nephrology(Carton) ,2009,14(5) :527-532.
6Zou Y, Stastny P. The role of major histocompatibility complexclass chain- related gene A antibodies in organ transplantation.Curr Opin Organ Transplant,2009,14(4) :414-418.
7Sun Q, Cheng Z,Cheng D, et al. De novo development of circu-lating anti-endothelial cell antibodies rather than pre-existinganti-bodies is associated with post-transplant allograft rejection. KidneyInt,2011 ,79(6) :655-662.
8Nakagawa Y,Saito K,Morioka T,et al. The clinical significanceof antibody to vascular endothelial cells after renal transplanta-tion. Clin Transplant ,2002,16 ( Suppl8) :51-57.
